TransCode Therapeutics
Pre-clinicalTransCode Therapeutics focused on treating metastatic disease
Founded
2016
Focus
DiagnosticsDrug DeliveryRNA & Gene Therapy
About
TransCode Therapeutics focused on treating metastatic disease
Funding History
4Total raised: $23.8M
PIPE$5MUndisclosedMar 15, 2023
IPO$10.5MThinkEquityJul 16, 2021
Series A$6.3MUndisclosedDec 15, 2020
Seed$2MUndisclosedAug 15, 2019
Company Info
TypePrivate
Founded2016
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile